178 related articles for article (PubMed ID: 11790236)
1. Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study.
Vorgerd M; Zange J; Kley R; Grehl T; Hüsing A; Jäger M; Müller K; Schröder R; Mortier W; Fabian K; Malin JP; Luttmann A
Arch Neurol; 2002 Jan; 59(1):97-101. PubMed ID: 11790236
[TBL] [Abstract][Full Text] [Related]
2. Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial.
Vorgerd M; Grehl T; Jager M; Muller K; Freitag G; Patzold T; Bruns N; Fabian K; Tegenthoff M; Mortier W; Luttmann A; Zange J; Malin JP
Arch Neurol; 2000 Jul; 57(7):956-63. PubMed ID: 10891977
[TBL] [Abstract][Full Text] [Related]
3. Dose-response effect of pre-exercise carbohydrates under muscle glycogen unavailability: Insights from McArdle disease.
Valenzuela PL; Santalla A; Alejo LB; Merlo A; Bustos A; Castellote-Bellés L; Ferrer-Costa R; Maffiuletti NA; Barranco-Gil D; Pinós T; Lucia A
J Sport Health Sci; 2024 May; 13(3):398-408. PubMed ID: 38030066
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Quinlivan R; Martinuzzi A; Schoser B
Cochrane Database Syst Rev; 2010 Dec; (12):CD003458. PubMed ID: 21154353
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: a randomized, double-blind, placebo-controlled, crossover trial.
Hayashi AP; Solis MY; Sapienza MT; Otaduy MC; de Sá Pinto AL; Silva CA; Sallum AM; Pereira RM; Gualano B
Lupus; 2014 Dec; 23(14):1500-11. PubMed ID: 25135060
[TBL] [Abstract][Full Text] [Related]
6. Effect of changes in fat availability on exercise capacity in McArdle disease.
Andersen ST; Jeppesen TD; Taivassalo T; Sveen ML; Heinicke K; Haller RG; Vissing J
Arch Neurol; 2009 Jun; 66(6):762-6. PubMed ID: 19506137
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral sucrose shortly before exercise on work capacity in McArdle disease.
Andersen ST; Haller RG; Vissing J
Arch Neurol; 2008 Jun; 65(6):786-9. PubMed ID: 18541798
[TBL] [Abstract][Full Text] [Related]
8. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study.
Kornblum C; Schröder R; Müller K; Vorgerd M; Eggers J; Bogdanow M; Papassotiropoulos A; Fabian K; Klockgether T; Zange J
Eur J Neurol; 2005 Apr; 12(4):300-9. PubMed ID: 15804248
[TBL] [Abstract][Full Text] [Related]
9. Can a modified ketogenic diet be a nutritional strategy for patients with McArdle disease? Results from a randomized, single-blind, placebo-controlled, cross-over study.
Løkken N; Nielsen MR; Stemmerik MG; Ellerton C; Revsbech KL; Macrae M; Slipsager A; Krett B; Beha GH; Emanuelsson F; van Hall G; Quinlivan R; Vissing J
Clin Nutr; 2023 Nov; 42(11):2124-2137. PubMed ID: 37769369
[TBL] [Abstract][Full Text] [Related]
10. Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study.
Banerjee B; Sharma U; Balasubramanian K; Kalaivani M; Kalra V; Jagannathan NR
Magn Reson Imaging; 2010 Jun; 28(5):698-707. PubMed ID: 20395096
[TBL] [Abstract][Full Text] [Related]
11. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study.
Walter MC; Lochmüller H; Reilich P; Klopstock T; Huber R; Hartard M; Hennig M; Pongratz D; Müller-Felber W
Neurology; 2000 May; 54(9):1848-50. PubMed ID: 10802796
[TBL] [Abstract][Full Text] [Related]
12. Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle.
Vorgerd M; Zange J
Acta Myol; 2007 Jul; 26(1):61-3. PubMed ID: 17915573
[TBL] [Abstract][Full Text] [Related]
13. Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial.
Chung YL; Alexanderson H; Pipitone N; Morrison C; Dastmalchi M; Ståhl-Hallengren C; Richards S; Thomas EL; Hamilton G; Bell JD; Lundberg IE; Scott DL
Arthritis Rheum; 2007 May; 57(4):694-702. PubMed ID: 17471547
[TBL] [Abstract][Full Text] [Related]
14. No effect of triheptanoin on exercise performance in McArdle disease.
Madsen KL; Laforêt P; Buch AE; Stemmerik MG; Ottolenghi C; Hatem SN; Raaschou-Pedersen DT; Poulsen NS; Atencio M; Luton MP; Ceccaldi A; Haller RG; Quinlivan R; Mochel F; Vissing J
Ann Clin Transl Neurol; 2019 Oct; 6(10):1949-1960. PubMed ID: 31520525
[TBL] [Abstract][Full Text] [Related]
15. Genes and exercise intolerance: insights from McArdle disease.
Nogales-Gadea G; Godfrey R; Santalla A; Coll-Cantí J; Pintos-Morell G; Pinós T; Arenas J; Martín MA; Lucia A
Physiol Genomics; 2016 Feb; 48(2):93-100. PubMed ID: 26465709
[TBL] [Abstract][Full Text] [Related]
16. Creatine supplementation--part I: performance, clinical chemistry, and muscle volume.
Kamber M; Koster M; Kreis R; Walker G; Boesch C; Hoppeler H
Med Sci Sports Exerc; 1999 Dec; 31(12):1763-9. PubMed ID: 10613426
[TBL] [Abstract][Full Text] [Related]
17. Dantrolene sodium does influence the second-wind phenomenon in McArdle's disease. Electrophysiological evidence during exercise in a double-blind placebo-controlled, cross-over study in 5 patients.
Poels PJ; Braakhekke JP; Joosten EM; Stegeman DF
J Neurol Sci; 1990 Dec; 100(1-2):108-12. PubMed ID: 2089128
[TBL] [Abstract][Full Text] [Related]
18. Repeated oral sucrose dosing after the second wind is unnecessary in patients with McArdle disease: Results from a randomized, placebo-controlled, double-blind, cross-over study.
Løkken N; Khawajazada T; Slipsager A; Voermans NC; Vissing J
J Inherit Metab Dis; 2023 Nov; 46(6):1139-1146. PubMed ID: 37431283
[TBL] [Abstract][Full Text] [Related]
19. Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease.
Martinuzzi A; Liava A; Trevisi E; Frare M; Tonon C; Malucelli E; Manners D; Kemp GJ; Testa C; Barbiroli B; Lodi R
Muscle Nerve; 2008 Mar; 37(3):350-7. PubMed ID: 18098237
[TBL] [Abstract][Full Text] [Related]
20. A case of McArdle disease: efficacy of vitamin B6 on fatigability and impaired glycogenolysis.
Izumi R; Suzuki N; Kato K; Warita H; Tateyama M; Nakashima I; Itoyama Y
Intern Med; 2010; 49(15):1623-5. PubMed ID: 20686302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
